Log in or Sign up for Free to view tailored content for your specialty!
Gastroenterology News
GLP-1 receptor agonists ‘have changed the playing field’ in pediatric MASLD
WASHINGTON — Glucagon-like peptide-1 receptor agonists significantly reduced alanine aminotransferase levels in pediatric metabolic dysfunction-associated steatotic liver disease, especially those with type 2 diabetes, researchers reported.
Recalled cucumbers may be cause of ongoing Salmonella outbreak
The CDC on Wednesday announced that recalled cucumbers have been identified as the potential cause of an ongoing Salmonella outbreak.
Log in or Sign up for Free to view tailored content for your specialty!
A 100% response rate suggests dostarlimab is ‘definitive’ therapy for rectal cancer
CHICAGO — A phase 2 study evaluating dostarlimab in adults with mismatch repair-deficient locally advanced rectal cancer has maintained a 100% clinical complete response rate at a median follow-up of almost 18 months.
‘Promise of lasting efficacy’: Guselkumab outperforms placebo, ustekinumab in Crohn’s
WASHINGTON — In patients with active Crohn’s disease, guselkumab was superior to both placebo and standard-of-care ustekinumab after 48 weeks of treatment, according to late-breaking data from the phase 3 GALAXI program.
VIDEO: Results from SEQUENCE trial ‘important’ for treatment selection in Crohn’s
In this Healio video, Uma Mahadevan, MD, director of the Colitis and Crohn’s Disease Center at the University of California, San Francisco, recaps results from the SEQUENCE trial, which were presented at Digestive Disease Week 2024.
VIDEO: Lifestyle modifications must be ‘personalized to the patient’ in GERD management
WASHINGTON — In a Healio video exclusive, Carolyn Newberry, MD, discusses the importance of “personalized” lifestyle modifications, such as identifying dietary triggers and being mindful of meal-timing, for the management of GERD.
CDC: Hepatitis C clearance rates well below national elimination goals
Hepatitis C virus clearance rates in all states fell well short of national elimination goals, a study published in MMWR showed.
Evolocumab shows particular CV benefit in those with autoimmune disease, inflammation
Patients with atherosclerosis and elevated LDL plus autoimmune or inflammatory disease may derive particular CV benefit from PCSK9 inhibition with evolocumab, a speaker reported.
VIDEO: ‘Compelling data’ from VIVID-1 study support use of mirikizumab in Crohn’s disease
WASHINGTON — In this video, Mark Genovese, MD, discusses results of the VIVID-1 study, in which mirikizumab demonstrated noninferiority to ustekinumab for week 52 clinical remission among patients with moderate to severe Crohn’s disease.
A catered low-fat, high-fiber diet ‘new, hopeful option’ to manage Crohn’s disease
WASHINGTON — Patients with Crohn’s disease who ate a catered low-fat, high-fiber diet for 8 weeks experienced improvements in symptoms, inflammation and quality of life vs. those offered counseling alone, researchers reported.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read